AmSurg Corp (EVHC):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AmSurg Corp (EVHC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3426
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AmSurg Corp (AmSurg) is a healthcare service provider that develops, acquires and operates surgery centers. The company is a surgery center management and development company that manages hospitals and health systems. It provides strategic and operational management of surgery centers that include endoscopy, ophthalmology and orthopaedics. AmSurg’s physician services division provides health care solutions for anesthesiology and other specialties such as emergency medicine and radiology to physicians, hospitals and outpatient surgery centers. It offers clinical solutions to support health systems, communities and payors. The company operates throught its centres that include Alabama, Arizona, Arkansas, California Colorado, Connecticut, Delaware, District of Columbia, Florida, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana and Maryland, among others. AmSurg is headquartered in Nashville, Tennessee, the US.

AmSurg Corp (EVHC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AmSurg Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AmSurg Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AmSurg Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AmSurg Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AmSurg Corp, Medical Devices Deals, 2012 to YTD 2018 9
AmSurg Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AmSurg Corp, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
AmSurg Raises USD172.5 Million in Public Offering of Preferred Stock 11
AmSurg Raises USD439.8 Million in Public Offering of Shares 13
Sheridan Healthcare Rumored To Issue Shares In IPO For Up To US$500 Million 15
Debt Offering 16
AmSurg Prices Private Placement of 5.625% Notes Due 2022 for USD1.1 Billion 16
AmSurg Completes Private Placement Of Notes Due 2020 For US$250 Million 17
Acquisition 18
AmSurg Acquires Bay Area Anesthesia 18
Sheridan Healthcare Acquires Coastal Anesthesiology 19
Sheridan Healthcare Acquires Halifax Anesthesiology Associates 20
Sheridan Healthcare Acquires Radiology Associates of Hollywood 21
AmSurg Completes Acquisition of Sheridan Healthcare from Hellman & Friedman for USD2.35 Billion 22
Sheridan Healthcare Acquires Medical Anesthesia Consultants 24
AmSurg Corp – Key Competitors 25
AmSurg Corp – Key Employees 26
AmSurg Corp – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
AmSurg Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
AmSurg Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AmSurg Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AmSurg Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AmSurg Corp, Deals By Therapy Area, 2012 to YTD 2018 8
AmSurg Corp, Medical Devices Deals, 2012 to YTD 2018 9
AmSurg Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AmSurg Raises USD172.5 Million in Public Offering of Preferred Stock 11
AmSurg Raises USD439.8 Million in Public Offering of Shares 13
Sheridan Healthcare Rumored To Issue Shares In IPO For Up To US$500 Million 15
AmSurg Prices Private Placement of 5.625% Notes Due 2022 for USD1.1 Billion 16
AmSurg Completes Private Placement Of Notes Due 2020 For US$250 Million 17
AmSurg Acquires Bay Area Anesthesia 18
Sheridan Healthcare Acquires Coastal Anesthesiology 19
Sheridan Healthcare Acquires Halifax Anesthesiology Associates 20
Sheridan Healthcare Acquires Radiology Associates of Hollywood 21
AmSurg Completes Acquisition of Sheridan Healthcare from Hellman & Friedman for USD2.35 Billion 22
Sheridan Healthcare Acquires Medical Anesthesia Consultants 24
AmSurg Corp, Key Competitors 25
AmSurg Corp, Key Employees 26
AmSurg Corp, Other Locations 27
AmSurg Corp, Subsidiaries 27

List of Figures
AmSurg Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AmSurg Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AmSurg Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AmSurg Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AmSurg Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AmSurg Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AmSurg Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AmSurg Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AmSurg Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[AmSurg Corp (EVHC):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Abide Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Abide Therapeutics Inc (Abide) is a clinical development stage company that discovers and develops therapeutic potential of serine hydrolases to transform the lives of patients with serious unmet medical needs. The company’s pipeline include ABX-1431, a first-in-class inhibitor of the serine …
  • Samsung Medison Co Ltd:企業の戦略的SWOT分析
    Samsung Medison Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • ACWA Power Barka SAOG (APBS):企業の財務・戦略的SWOT分析
    ACWA Power Barka SAOG (APBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • ITT Inc.:企業のM&A・事業提携・投資動向
    ITT Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ITT Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Triphase Accelerator Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Triphase Accelerator Corp (Triphase Accelerator) is a biotechnology development company that acquires and develops novel therapeutics for the treatment of cancer. The company's pipeline products comprise marizomib, a brain-penetrant proteasome inhibitor, which is developed in both intravenou …
  • Sun Hung Kai Properties Ltd:企業の戦略・SWOT・財務分析
    Sun Hung Kai Properties Ltd - Strategy, SWOT and Corporate Finance Report Summary Sun Hung Kai Properties Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Paramount Resources Ltd (POU):企業の財務・戦略的SWOT分析
    Summary Paramount Resources Ltd (Paramount Resources) is an energy company that offers exploration, production, development, and marketing of oil and gas products. The company offers products such s crude oil, fuel oil, natural gas and natural gas liquids. It operates in three segments such as princ …
  • Canadian Western Bank Group (CWB):企業の財務・戦略的SWOT分析
    Canadian Western Bank Group (CWB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Cimab SA-製薬・医療分野:企業M&A・提携分析
    Summary Cimab SA (Cimab) is a biopharmaceutical company that develops and markets monoclonal antibodies and other recombinant proteins for the diagnosis and treatment of cancer and other diseases related to the immune system. The company offers products such as cimaher nimotuzumab, ior epocim epoeti …
  • Yes Bank Ltd
    Yes Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Yes Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Assembly Biosciences Inc (ASMB):企業の財務・戦略的SWOT分析
    Summary Assembly Biosciences Inc (Assembly), formerly Ventrus Biosciences Inc is a biotechnology company that develops, discovers, and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as microbiotic therapies for Clostridium diffic …
  • Autoliv Inc (ALV):企業の財務・戦略的SWOT分析
    Autoliv Inc (ALV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Kenya Power and Lighting Co Ltd (KPLA):企業の財務・戦略的SWOT分析
    Kenya Power and Lighting Co Ltd (KPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Aclara Technologies LLC-エネルギー分野:企業M&A・提携分析
    Summary Aclara Technologies LLC (Aclara), as a subsidiary of Sun Capital Partners, Inc. The company designs, develops and commercializes Advanced Metering Infrastructure (AMI) solutions for data value management, customer communication and device networking activities. It provides an array of custom …
  • Sudarshan Chemical Industries Ltd (SUDARSCHEM):企業の財務・戦略的SWOT分析
    Sudarshan Chemical Industries Ltd (SUDARSCHEM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Hammerson plc:企業のM&A・事業提携・投資動向
    Hammerson plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hammerson plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Ferndale Pharma Group Inc-製薬・医療分野:企業M&A・提携分析
    Summary Ferndale Pharma Group Inc (Ferndale Pharma), formerly Ferndale Laboratories Inc is a manufacturer and distributor of pharmaceutical products. The company provides surgical instruments, medical supplies, skin care products, topical therapeutic products, prescription, over the counter products …
  • Brunei National Petroleum Company Sendirian Berhad:石油・ガス:M&Aディール及び事業提携情報
    Summary Brunei National Petroleum Company Sendirian Berhad (PetroleumBRUNEI) is an oil and gas company that provides exploration and production of oil and gas. The company offers engineering, procurement, construction, installation, commissioning services, and others. It provides oilfield services, …
  • TaiMed Biologics Inc (4147):製薬・医療:M&Aディール及び事業提携情報
    Summary TaiMed Biologics Inc (TMB) is a biotechnology company that provides novel medicines for the prevention and treatment of viral infectious diseases. The company provides pipeline products such as TMB-355, TMB-607 and TMB-571, among others. It offers TMB-355 which is a proprietary humanized ant …
  • Development Bank of Japan Inc:企業のM&A・事業提携・投資動向
    Development Bank of Japan Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Development Bank of Japan Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆